New antibody drug, MPDL3280A, in non-small cell lung cancer
3 Oct 2013
New antibody drug, MPDL3280A, in non-small cell lung cancer
Prevention benefit from vitamin D
Meta-analysis of ipilimumab in metastatic or locally advanced, unresectable melanoma
Advances in patient management through web and mobile based applications
Standardised and centralised care of sarcomas
Biomarkers in the BOLERO3 trial
FLIMS workshop: Methods in clinical cancer research
Androgen blockade and ipilimumab against castration resistant prostate cancer
Observational RASTER study on the 70-gene-signature
Nursing highlights from ECC 2013
The 'Make Sense Campaign' for head and neck cancer awareness
Outcomes of early stage ovarian endometrioid carcinoma